Two biomarker tests -- one for blood and the other for stool -- are mainstays in the treatment of inflammatory bowel disease ...

Note that some links may require registration or subscription. HHS announced an investigation into a major Michigan health ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...

"It's not just taking something away, but really doing a careful assessment of how that medication works within that ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

In this final MedPage Today video from the conference, AACE President Scott D. Isaacs, MD, of Emory University School of Medicine in Atlanta, reflects on that session and underscores the enduring ...

Prior authorization varies by plan but often requires patients or their providers to get permission (also called ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...

CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...

Maertens reported relationships with F2G, Cidara, Pfizer, Gilead, MSD, Takeda, Mundipharma, Basilea, and Shionogi. Co-authors ...

Over a median follow-up of 7 years, breast cancer survivors had an 8% lower risk of Alzheimer's dementia compared with ...